Posts Tagged ‘Vasovist’

Contrast Imaging Agent Gets FDA Approval

Monday, January 5th, 2009

The U.S. Food and Drug Administration (FDA) has approved Vasovist® (gadofosveset trisodium), a new injectable contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).

Read more »